ReviewJournal of cancer education : the official journal of the American Association for Cancer Education2025
Cannabis Use Among Adolescents and Young Adults with Cancer: A Scoping Review.
Review in Journal of cancer education : the official journal of the American Association for Cancer Education, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
There have been recent increases in cannabis use for medical and non-medical (i.e., "recreational") purposes. One prominent medical use is for cancer-related symptoms. Young adults with a cancer history may have unique cannabis use characteristics, yet little research has examined this topic. This scoping review assessed the literature on cannabis use among young adults with a history of cancer. In October 2024, we conducted a MEDLINE/PubMed search for empirical, peer-reviewed articles written in English. Inclusion criteria were (1) primary research, (2) included participants ages 18-39 previously diagnosed with cancer, (3) included data on cannabis use, and (4) written in English. This review included 15 articles, which varied in timing of cancer diagnosis (e.g., childhood, adolescence, young adulthood) and age at data collection (e.g., 15-25, 18-39). Most (n = 11) were cross-sectional survey studies; others were longitudinal (n = 2), observational (n = 1), or chart reviews (n = 1). Results varied regarding cannabis use prevalence among cancer survivors compared to peers without a cancer diagnosis, as well as whether certain treatment-related factors were associated with use. Several studies documented medical use motives (e.g., nausea, pain, insomnia, mood), with some indication of effectiveness. Existing research has largely focused on medical use and use during treatment; less research has assessed use outside of cancer treatment or for non-medical reasons among individuals with a cancer diagnosis. Young adults with a cancer history may have unique cannabis use characteristics given their likely use for both medical and non-medical purposes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.